Frank Balis, MD, Chairs National Panel that Released First-ever Treatment Guidelines for Wilms Tumor
Feb 25, 2021
The National Comprehensive Cancer Network (NCCN) recently published its first-ever treatment guidelines for Wilms' tumor.
Cancer Center News
Your child will be cared for by one of the most accomplished teams of childhood cancer experts in the world. We provide medical care, emotional counseling and much more. We make sure your child, you and every family member get the highest level of support.
Existing patients or family members
New patients, referrals and second opinions
Case Study: Concurrent Bilateral Partial Nephrectomies for Wilms Tumors
Feb 22, 2021
A multispecialty collaboration of oncology, urology, and radiology saved the patient from undergoing two rounds of anesthesia.
FDA Approves Drug for Rare Form of Pediatric Cancer
Jan 15, 2021
The FDA has approved a treatment that targets ALK mutations in relapsed, refractory ALK-positive anaplastic large cell lymphoma.
CHOP Researchers Find Elevated Biomarker Related to Blood Vessel Damage in All Children with SARS-CoV-2 Regardless of Disease Severity
Dec 8, 2020
CHOP researchers found the elevated biomarker in all children who tested positive for SARS-CoV-2, whether they were symptomatic for COVID-19 or not.
Yael Mossé, MD, Featured by the Conquer Cancer Foundation
Dec 7, 2020
The CHOP physician-researcher’s investigation into cause of and treatment for neuroblastoma has been supported by Conquer Cancer grants.
Pediatric Cancer Researchers Receive $1.3 Million to Study Precise Treatment for Neuroblastoma
Nov 16, 2020
Grant awarded to CHOP and Gustave Roussy to support phase 3 clinical trial developed by Children’s Oncology Group and International Society of Paediatric Oncology Europe Neuroblastoma Group, representing first-ever collaboration between North American and European neuroblastoma consortia.
Case Study: Osteosarcoma and Limb Salvage Surgery
Nov 13, 2020
Read this case study about a patient who received treatment for osteosarcoma and underwent limb salvage surgery at Children’s Hospital of Philadelphia.
CHOP Participates in a Multi-institutional Clinical Trial Leading to First-Ever Therapy for Neurofibromatosis Type 1
Oct 6, 2020
New therapy shrinks tumors associated with NF1 and improves quality of life.
CHOP Researchers Use Precision Medicine to Reverse Severe Lymphatic Disorder in a Patient with KLA
Oct 5, 2020
Using genetic sequencing and targeted treatment, CHOP researchers resolved a severe lymphatic disorder in a young woman with KLA, a complex and rare disorder.
Small Study Shows Convalescent Plasma is Safe to Use in Pediatric Patients with COVID-19
Sep 8, 2020
CHOP researchers show convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19.